-Livemint.com Plant varieties and seeds cannot be patented under Indian law by companies like Monsanto, and any royalties on GM crops will be decided by the agriculture ministry, says Delhi high court New Delhi: Plant varieties and seeds cannot be patented under Indian law by companies like Monsanto Inc., and any royalties on genetically modified (GM) technology will be decided by a specialized agency of the agriculture ministry, the Delhi high court...

-The Hindu Why India is the only Bt cotton-growing country facing the problem of pink bollworm infestation Earlier this month, the government cut royalties that local seed companies pay to Monsanto, for the second time in two years. This follows previous attempts to defang Monsanto. In February, for instance, the anti-trust regulator, the Competition Commission of India, decided to probe into anti-competitive practices by Monsanto. At the centre of all this is...

-The Hindu Business Line Asks firm to own up responsibility; threatens to stop selling seeds Hyderabad: The National Seed Association of India, which represents the majority of the cotton seed companies in the country, has blamed Mahyco Monsanto and Monsanto India for widespread resistance developed by pink bollworm to Bollgard-II, the second-generation genetically modified cotton seed technology. The association has threatened to stop selling the seeds developed with BG-II technology if the two...

-The Hindu While Monsanto and Indian seed companies spar, more worrying is the confused lawmaking underpinning regulation of patents Genetically Modified Organisms (GMOs) breed controversy like no other. Little wonder then that Monsanto’s much-maligned Bt cotton has spawned the mother of all intellectual property (IP) disputes in India, involving at least 15 different proceedings in various courts, government agencies and tribunals at last count. Most proceedings appear to have come at the behest...

-The Hindu New Delhi: Seed technology major Monsanto says it is suspending plans to introduce an upgraded version of its genetically modified cotton in India because of uncertainty in the “business and regulatory environment”. Activists say this is a “hypocritical” position. On July 6, Monsanto notified the Genetic Engineering Appraisal Committee, the regulatory authority for approval of biotechnology traits in India, that it was withdrawing its application for the commercial release of...